866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Bioengineered Protein Drugs Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 110 Pages

In this report, the EMEA Bioengineered Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Bioengineered Protein Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Bioengineered Protein Drugs market competition by top manufacturers/players, with Bioengineered Protein Drugs sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Amgen, Inc.
Bayer AG
Merck & Co., Inc.
Dr. Reddys Laboratories Ltd.
Biocon Ltd.
Eli Lilly and Company
Sanofi
GlaxoSmithKline plc
Johnson & Johnson
JanssenNovartis AG
Panacea Biotec
ProBioGen AG

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into
Therapeutic Proteins
Monoclonal Antibodies
Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Bioengineered Protein Drugs for each application, including
Diabetes and Hormonal Disorders
Genetic and Fertility Disorders
Cancers
Organ Transplants
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Bioengineered Protein Drugs Market Report 2017
1 Bioengineered Protein Drugs Overview
1.1 Product Overview and Scope of Bioengineered Protein Drugs
1.2 Classification of Bioengineered Protein Drugs
1.2.1 EMEA Bioengineered Protein Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Bioengineered Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Therapeutic Proteins
1.2.4 Monoclonal Antibodies
1.2.5 Vaccines
1.3 EMEA Bioengineered Protein Drugs Market by Application/End Users
1.3.1 EMEA Bioengineered Protein Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Diabetes and Hormonal Disorders
1.3.3 Genetic and Fertility Disorders
1.3.4 Cancers
1.3.5 Organ Transplants
1.3.6 Others
1.4 EMEA Bioengineered Protein Drugs Market by Region
1.4.1 EMEA Bioengineered Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Bioengineered Protein Drugs (2012-2022)
1.5.1 EMEA Bioengineered Protein Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Bioengineered Protein Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Bioengineered Protein Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Bioengineered Protein Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Bioengineered Protein Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Bioengineered Protein Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Bioengineered Protein Drugs Sale Price by Players (2012-2017)
2.2 EMEA Bioengineered Protein Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Bioengineered Protein Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Bioengineered Protein Drugs Sale Price by Type (2012-2017)
2.3 EMEA Bioengineered Protein Drugs (Volume) by Application
2.4 EMEA Bioengineered Protein Drugs (Volume and Value) by Region
2.4.1 EMEA Bioengineered Protein Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Bioengineered Protein Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Bioengineered Protein Drugs Sales Price by Region (2012-2017)

3 Europe Bioengineered Protein Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Bioengineered Protein Drugs Sales and Value (2012-2017)
3.1.1 Europe Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Bioengineered Protein Drugs Sales and Market Share by Type
3.3 Europe Bioengineered Protein Drugs Sales and Market Share by Application
3.4 Europe Bioengineered Protein Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Bioengineered Protein Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Bioengineered Protein Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

4 Middle East Bioengineered Protein Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Bioengineered Protein Drugs Sales and Value (2012-2017)
4.1.1 Middle East Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Bioengineered Protein Drugs Sales and Market Share by Type
4.3 Middle East Bioengineered Protein Drugs Sales and Market Share by Application
4.4 Middle East Bioengineered Protein Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Bioengineered Protein Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Bioengineered Protein Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

5 Africa Bioengineered Protein Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Bioengineered Protein Drugs Sales and Value (2012-2017)
5.1.1 Africa Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Bioengineered Protein Drugs Sales and Market Share by Type
5.3 Africa Bioengineered Protein Drugs Sales and Market Share by Application
5.4 Africa Bioengineered Protein Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Bioengineered Protein Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Bioengineered Protein Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Bioengineered Protein Drugs Sales and Growth Rate (2012-2017)

6 EMEA Bioengineered Protein Drugs Manufacturers/Players Profiles and Sales Data
6.1 Abbott Laboratories
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche Ltd
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Amgen, Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Bayer AG
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bayer AG Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck & Co., Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Dr. Reddys Laboratories Ltd.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Dr. Reddys Laboratories Ltd. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biocon Ltd.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eli Lilly and Company
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline plc
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Bioengineered Protein Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 JanssenNovartis AG
6.13 Panacea Biotec
6.14 ProBioGen AG

7 Bioengineered Protein Drugs Manufacturing Cost Analysis
7.1 Bioengineered Protein Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bioengineered Protein Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Bioengineered Protein Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Bioengineered Protein Drugs Market Forecast (2017-2022)
11.1 EMEA Bioengineered Protein Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Bioengineered Protein Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Bioengineered Protein Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Bioengineered Protein Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Bioengineered Protein Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Bioengineered Protein Drugs
Figure EMEA Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2022)
Figure EMEA Bioengineered Protein Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Therapeutic Proteins Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Vaccines Product Picture
Figure EMEA Bioengineered Protein Drugs Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Bioengineered Protein Drugs by Application in 2016
Figure Diabetes and Hormonal Disorders Examples
Table Key Downstream Customer in Diabetes and Hormonal Disorders
Figure Genetic and Fertility Disorders Examples
Table Key Downstream Customer in Genetic and Fertility Disorders
Figure Cancers Examples
Table Key Downstream Customer in Cancers
Figure Organ Transplants Examples
Table Key Downstream Customer in Organ Transplants
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Bioengineered Protein Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Bioengineered Protein Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Bioengineered Protein Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Bioengineered Protein Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Bioengineered Protein Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Bioengineered Protein Drugs Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Bioengineered Protein Drugs Sales Share by Players (2012-2017)
Figure 2016 Bioengineered Protein Drugs Sales Share by Players
Figure 2017 Bioengineered Protein Drugs Sales Share by Players
Figure EMEA Bioengineered Protein Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Bioengineered Protein Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Bioengineered Protein Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Bioengineered Protein Drugs Revenue Share by Players
Table 2017 EMEA Bioengineered Protein Drugs Revenue Share by Players
Table EMEA Bioengineered Protein Drugs Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Bioengineered Protein Drugs Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Bioengineered Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Bioengineered Protein Drugs by Type (2012-2017)
Figure EMEA Bioengineered Protein Drugs Sales Market Share by Type (2012-2017)
Table EMEA Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Bioengineered Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Type in 2016
Table EMEA Bioengineered Protein Drugs Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Bioengineered Protein Drugs Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Bioengineered Protein Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Bioengineered Protein Drugs by Application (2012-2017)
Figure EMEA Bioengineered Protein Drugs Sales Market Share by Application in 2016
Table EMEA Bioengineered Protein Drugs Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Bioengineered Protein Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Bioengineered Protein Drugs by Region (2012-2017)
Figure EMEA Bioengineered Protein Drugs Sales Market Share in 2016
Table EMEA Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Bioengineered Protein Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Region (2012-2017)
Figure EMEA Bioengineered Protein Drugs Revenue Market Share Regions in 2016
Table EMEA Bioengineered Protein Drugs Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Europe Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
Table Europe Bioengineered Protein Drugs Sales (MT) by Type (2012-2017)
Table Europe Bioengineered Protein Drugs Market Share by Type (2012-2017)
Figure Europe Bioengineered Protein Drugs Market Share by Type in 2016
Table Europe Bioengineered Protein Drugs Sales (MT) by Application (2012-2017)
Table Europe Bioengineered Protein Drugs Market Share by Application (2012-2017)
Figure Europe Bioengineered Protein Drugs Market Share by Application in 2016
Table Europe Bioengineered Protein Drugs Sales (MT) by Countries (2012-2017)
Table Europe Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Bioengineered Protein Drugs Sales Market Share by Countries in 2016
Table Europe Bioengineered Protein Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Bioengineered Protein Drugs Revenue Market Share by Countries in 2016
Figure Germany Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure France Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UK Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Russia Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Italy Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Bioengineered Protein Drugs Sales (MT) by Type (2012-2017)
Table Middle East Bioengineered Protein Drugs Market Share by Type (2012-2017)
Figure Middle East Bioengineered Protein Drugs Market Share by Type (2012-2017)
Table Middle East Bioengineered Protein Drugs Sales (MT) by Applications (2012-2017)
Table Middle East Bioengineered Protein Drugs Market Share by Applications (2012-2017)
Figure Middle East Bioengineered Protein Drugs Sales Market Share by Application in 2016
Table Middle East Bioengineered Protein Drugs Sales Volume (MT) by Countries (2012-2017)
Table Middle East Bioengineered Protein Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Bioengineered Protein Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Bioengineered Protein Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Bioengineered Protein Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Israel Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UAE Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Iran Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Bioengineered Protein Drugs Sales (MT) by Type (2012-2017)
Table Africa Bioengineered Protein Drugs Sales Market Share by Type (2012-2017)
Figure Africa Bioengineered Protein Drugs Sales Market Share by Type (2012-2017)
Figure Africa Bioengineered Protein Drugs Sales Market Share by Type in 2016
Table Africa Bioengineered Protein Drugs Sales (MT) by Application (2012-2017)
Table Africa Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Figure Africa Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Table Africa Bioengineered Protein Drugs Sales Volume (MT) by Countries (2012-2017)
Table Africa Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Bioengineered Protein Drugs Sales Market Share by Countries in 2016
Table Africa Bioengineered Protein Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Bioengineered Protein Drugs Revenue Market Share by Countries in 2016
Figure South Africa Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Table Abbott Laboratories Bioengineered Protein Drugs Basic Information List
Table Abbott Laboratories Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Amgen, Inc. Bioengineered Protein Drugs Basic Information List
Table Amgen, Inc. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen, Inc. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Amgen, Inc. Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Amgen, Inc. Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Bioengineered Protein Drugs Basic Information List
Table Bayer AG Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer AG Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Bayer AG Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc. Bioengineered Protein Drugs Basic Information List
Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Dr. Reddys Laboratories Ltd. Bioengineered Protein Drugs Basic Information List
Table Dr. Reddys Laboratories Ltd. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dr. Reddys Laboratories Ltd. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Dr. Reddys Laboratories Ltd. Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Dr. Reddys Laboratories Ltd. Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Biocon Ltd. Bioengineered Protein Drugs Basic Information List
Table Biocon Ltd. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Ltd. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Biocon Ltd. Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Biocon Ltd. Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Bioengineered Protein Drugs Basic Information List
Table Eli Lilly and Company Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi Bioengineered Protein Drugs Basic Information List
Table Sanofi Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc Bioengineered Protein Drugs Basic Information List
Table GlaxoSmithKline plc Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc Bioengineered Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Bioengineered Protein Drugs Basic Information List
Table JanssenNovartis AG Bioengineered Protein Drugs Basic Information List
Table Panacea Biotec Bioengineered Protein Drugs Basic Information List
Table ProBioGen AG Bioengineered Protein Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioengineered Protein Drugs
Figure Manufacturing Process Analysis of Bioengineered Protein Drugs
Figure Bioengineered Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2016
Table Major Buyers of Bioengineered Protein Drugs
Table Distributors/Traders List
Figure EMEA Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Bioengineered Protein Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Bioengineered Protein Drugs Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Bioengineered Protein Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Bioengineered Protein Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Bioengineered Protein Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Bioengineered Protein Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Bioengineered Protein Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Bioengineered Protein Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Bioengineered Protein Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Bioengineered Protein Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Bioengineered Protein Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Bioengineered Protein Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Bioengineered Protein Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Bioengineered Protein Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Bioengineered Protein Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Bioengineered Protein Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Bioengineered Protein Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Bioengineered Protein Drugs Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Bioengineered Protein Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Bioengineered Protein Drugs Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Bioengineered Protein Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *